|
Michael A. Mesenbrink (59), Class I Director, is currently a venture partner with Vangel Capital Group and prior to that was CEO of Center For Advanced Laparoscopic Surgery, a national bariatric surgery practice and company, and has been in the medical device and health care industry for 32 years. He has served as CEO of a multi national sports medicine company, Innovation Sports, Inc. and Executive Vice President of a public medical device company, Medstone International. He was co founder of Medical Imaging Centers of America (MICA) that went public and had a market capitalization of $225 million. Mr. Mesenbrink was formerly with Johnson & Johnson; Becton-Dickinson and has founded several companies and held many senior management roles in cardiovascular, surgery, and radiology product based companies. Mr. Mesenbrink received a BA degree in Zoology/Chemistry from San Jose State University in 1970 and did postgraduate studies at the Menai Bridge Ocean Science Laboratories, University of Wales, U.K. Mr. Mesenbrink has been a director of the Company since 2002. | 